Erasca (ERAS) Change in Account Payables (2020 - 2026)
Erasca posted quarterly Change in Account Payables of $1.2 million for Q1 2026, down 34.11% year-on-year from $1.8 million in Q1 2025, and up 157.71% on a QoQ basis from -$2.0 million in Q4 2025.
Erasca (ERAS) has 7 years of Change in Account Payables data on file, last reported at $1.2 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 34.11% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at -$99000.0 (up 73.32% YoY), and the FY2025 full-year result was $513000.0, up 133.49% from the prior year.
- Change in Account Payables for Q1 2026 stood at $1.2 million, up from -$2.0 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $1.9 million in Q1 2022 and bottomed at -$2.0 million in Q4 2025.
- The 5-year median for Change in Account Payables is $446000.0 (2023), against an average of -$2764.7.
- Peak annual rise in Change in Account Payables reached 992.4% in 2022, while the deepest fall reached 565.19% in 2022.
- A 5-year view of Change in Account Payables shows it stood at -$864000.0 in 2022, then plunged by 92.48% to -$1.7 million in 2023, then slipped by 16.48% to -$1.9 million in 2024, then dropped by 5.73% to -$2.0 million in 2025, then surged by 157.71% to $1.2 million in 2026.
- The last three Change in Account Payables figures came in at $1.2 million (Q1 2026), -$2.0 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Erasca | 4.21 Bn | 3.97 Bn | - | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.18 Mn |
| Mar 31, 2026 | 1.18 Mn |
| Dec 31, 2025 | -2.05 Mn |
| Dec 31, 2025 | -2.05 Mn |
| Sep 30, 2025 | 1.37 Mn |
| Sep 30, 2025 | 1.37 Mn |
| Jun 30, 2025 | -599,000.00 |
| Jun 30, 2025 | -599,000.00 |
| Mar 31, 2025 | 1.79 Mn |
| Mar 31, 2025 | 1.79 Mn |
| Dec 31, 2024 | -1.94 Mn |
| Dec 31, 2024 | -1.94 Mn |
| Sep 30, 2024 | 482,000.00 |
| Sep 30, 2024 | 482,000.00 |
| Jun 30, 2024 | -710,000.00 |
| Jun 30, 2024 | -710,000.00 |
| Mar 31, 2024 | 633,000.00 |
| Mar 31, 2024 | 633,000.00 |
| Dec 31, 2023 | -1.66 Mn |
| Dec 31, 2023 | -1.66 Mn |
| Sep 30, 2023 | 1.03 Mn |
| Sep 30, 2023 | 1.03 Mn |
| Jun 30, 2023 | -701,000.00 |
| Jun 30, 2023 | -701,000.00 |
| Mar 31, 2023 | 446,000.00 |
| Mar 31, 2023 | 446,000.00 |
| Dec 31, 2022 | -864,000.00 |
| Dec 31, 2022 | -864,000.00 |
| Sep 30, 2022 | 1.53 Mn |
| Sep 30, 2022 | 1.53 Mn |
| Jun 30, 2022 | -1.88 Mn |
| Jun 30, 2022 | -1.88 Mn |
| Mar 31, 2022 | 1.90 Mn |
| Mar 31, 2022 | 1.90 Mn |
| Dec 31, 2021 | 935,000.00 |
| Dec 31, 2021 | 935,000.00 |
| Sep 30, 2021 | -171,000.00 |
| Sep 30, 2021 | -171,000.00 |
| Jun 30, 2021 | 405,000.00 |
| Jun 30, 2021 | 405,000.00 |
| Mar 31, 2021 | 175,000.00 |
| Mar 31, 2021 | 175,000.00 |
| Dec 31, 2020 | -1.39 Mn |
| Dec 31, 2020 | -1.39 Mn |
| Sep 30, 2020 | 1.53 Mn |
| Sep 30, 2020 | 1.53 Mn |